Researching ME/CFS: priority area
Researching ME/CFS: priority area supports researchers through grants and fellowships to study ME/CFS, address patient-led priorities and advance understanding, diagnosis and treatment.
Funder: UK Research and Innovation
Due Dates: Rolling (ME/CFS priority area; relevant MRC scheme deadlines apply)
Funding Amounts: Usually up to 80% of full economic cost; MRC grants typically run 12–60 months, subject to scheme rules
Summary: Supports high-quality ME/CFS research through MRC grant and fellowship schemes, particularly priorities identified by patients, carers and clinicians.
Key Information: Apply through an existing MRC funding opportunity appropriate to your science and career stage, meeting that scheme’s eligibility criteria.
Description
The Medical Research Council (MRC), part of UK Research and Innovation, supports research into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through its existing grant and fellowship opportunities. This priority area has operated since 2003 to strengthen the research portfolio and address unmet needs for better diagnosis and treatments.
MRC particularly welcomes research within its remit addressing priorities identified by the ME/CFS Priority Setting Partnership, led by people with ME/CFS, carers and clinicians. Applications should consider building research capacity, bringing together multidisciplinary expertise, and involving people living with ME/CFS in proposal development and throughout the project. Partnerships can include established investigators with relevant expertise who are new to the ME/CFS field.
